242 related articles for article (PubMed ID: 21152327)
1. Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.
Schneider H; Braun A; Füllekrug J; Stremmel W; Ehehalt R
Int J Mol Sci; 2010 Oct; 11(10):4149-64. PubMed ID: 21152327
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of phosphatidylcholine.
Treede I; Braun A; Sparla R; Kühnel M; Giese T; Turner JR; Anes E; Kulaksiz H; Füllekrug J; Stremmel W; Griffiths G; Ehehalt R
J Biol Chem; 2007 Sep; 282(37):27155-27164. PubMed ID: 17636253
[TBL] [Abstract][Full Text] [Related]
3. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
Braun A; Treede I; Gotthardt D; Tietje A; Zahn A; Ruhwald R; Schoenfeld U; Welsch T; Kienle P; Erben G; Lehmann WD; Fuellekrug J; Stremmel W; Ehehalt R
Inflamm Bowel Dis; 2009 Nov; 15(11):1705-20. PubMed ID: 19504612
[TBL] [Abstract][Full Text] [Related]
4. [Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis].
Stremmel W
Z Gastroenterol; 2013 Apr; 51(4):384-9. PubMed ID: 23585269
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevance.
Ehehalt R; Braun A; Karner M; Füllekrug J; Stremmel W
Biochim Biophys Acta; 2010 Sep; 1801(9):983-93. PubMed ID: 20595010
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells.
Treede I; Braun A; Jeliaskova P; Giese T; Füllekrug J; Griffiths G; Stremmel W; Ehehalt R
BMC Gastroenterol; 2009 Jul; 9():53. PubMed ID: 19594939
[TBL] [Abstract][Full Text] [Related]
7. Mucosal protection by phosphatidylcholine.
Stremmel W; Ehehalt R; Staffer S; Stoffels S; Mohr A; Karner M; Braun A
Dig Dis; 2012; 30 Suppl 3():85-91. PubMed ID: 23295697
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?
Stremmel W; Hanemann A; Ehehalt R; Karner M; Braun A
Dig Dis; 2010; 28(3):490-6. PubMed ID: 20926877
[TBL] [Abstract][Full Text] [Related]
9. Aloe vera mitigates dextran sulfate sodium-induced rat ulcerative colitis by potentiating colon mucus barrier.
Shi G; Jiang H; Feng J; Zheng X; Zhang D; Jiang C; Zhang J
J Ethnopharmacol; 2021 Oct; 279():114108. PubMed ID: 33839199
[TBL] [Abstract][Full Text] [Related]
10. Lecithin as a therapeutic agent in ulcerative colitis.
Stremmel W; Gauss A
Dig Dis; 2013; 31(3-4):388-90. PubMed ID: 24246994
[TBL] [Abstract][Full Text] [Related]
11. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S
J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745
[TBL] [Abstract][Full Text] [Related]
12. Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State.
Diab J; Hansen T; Goll R; Stenlund H; Ahnlund M; Jensen E; Moritz T; Florholmen J; Forsdahl G
Inflamm Bowel Dis; 2019 Oct; 25(11):1780-1787. PubMed ID: 31077307
[TBL] [Abstract][Full Text] [Related]
13. Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response.
Yin S; Yang H; Tao Y; Wei S; Li L; Liu M; Li J
Inflammation; 2020 Apr; 43(2):765-776. PubMed ID: 31897917
[TBL] [Abstract][Full Text] [Related]
14. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
Gan HT; Chen YQ; Ouyang Q
J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209
[TBL] [Abstract][Full Text] [Related]
15. KGF Is Delivered to Inflammatory and Induces the Epithelial Hyperplasia in Trinitrobenzene Sulfonic Acid-Induced Ulcerative Colitis Rats.
Jia K; Wang Y; Tong X; Wang R
Drug Des Devel Ther; 2020; 14():217-231. PubMed ID: 32021106
[TBL] [Abstract][Full Text] [Related]
16. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
Ren TH; Lv MM; An XM; Leung WK; Seto WK
J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673
[TBL] [Abstract][Full Text] [Related]
17. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
Gan H; Ouyang Q; Chen Y; Xia Q
Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
[TBL] [Abstract][Full Text] [Related]
18. Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis--a review of three clinical trials.
Stremmel W; Hanemann A; Braun A; Stoffels S; Karner M; Fazeli S; Ehehalt R
Expert Opin Investig Drugs; 2010 Dec; 19(12):1623-30. PubMed ID: 21105858
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
20. Genetic Mouse Models with Intestinal-Specific Tight Junction Deletion Resemble an Ulcerative Colitis Phenotype.
Stremmel W; Staffer S; Schneider MJ; Gan-Schreier H; Wannhoff A; Stuhrmann N; Gauss A; Wolburg H; Mahringer A; Swidsinski A; Efferth T
J Crohns Colitis; 2017 Oct; 11(10):1247-1257. PubMed ID: 28575164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
